Energy expenditure, nutrition status, and body composition in children with cystic fibrosis
- PMID:14962683
- DOI: 10.1016/j.nut.2003.10.010
Energy expenditure, nutrition status, and body composition in children with cystic fibrosis
Abstract
Objective: Undernutrition is a frequent complication in patients with cystic fibrosis (CF). Elevated energy requirements have been found to be 4% to 33% higher than in controls in some studies. Whether or not this is caused by a primary defect or energy metabolism is still a matter of controversy. To this end, we assessed energy expenditure, nutrition status, and body composition of clinically stable CF outpatients.
Methods: Fifteen clinically stable CF patients, ages 2 to 15 y, were paired with 15 healthy control children. Measurements consisted of anthropometry and body composition. Plasma tocopherol, retinol, and hair zinc content were measured. Resting energy expenditure was determined by indirect calorimetry. Physical activity and dietary intake were recorded by recall methods.
Results: Two children were nutritionally at risk according to the weight/height index, eight were normal, three were overweight, and two were obese. Body composition was similar in both groups. Zinc, tocopherol, and retinol levels were low in three, two, and three patients, respectively. Resting energy expenditures were 4.7 MJ/d (1127 +/- 220 kcal/d) in CF children and 4.63 MJ/d (1108 +/- 191 kcal/d) in control children (P = not significant). Physical activity level was sedentary in 86.6% of CF patients; the rest had a light physical activity pattern. Energy intake represented 141% of the estimated daily energy expenditure.
Conclusions: Non-oxygen-dependent CF children, without acute respiratory infection, had resting energy expenditures comparable to those of matched controls. Total energy expenditure was similar to or slightly lower than that in healthy children. Dietary recommendations for CF patients need to be reassessed.
Similar articles
- Adolescent development and energy expenditure in females with cystic fibrosis.Stallings VA, Tomezsko JL, Schall JI, Mascarenhas MR, Stettler N, Scanlin TF, Zemel BS.Stallings VA, et al.Clin Nutr. 2005 Oct;24(5):737-45. doi: 10.1016/j.clnu.2005.02.005. Epub 2005 Apr 8.Clin Nutr. 2005.PMID:16182037
- Variations in the measurement of resting energy expenditure in children with cystic fibrosis.Ashley MA, Broomhead L, Allen JR, Gaskin KJ.Ashley MA, et al.Eur J Clin Nutr. 2001 Oct;55(10):896-901. doi: 10.1038/sj.ejcn.1601244.Eur J Clin Nutr. 2001.PMID:11593352
- Resting energy expenditure of children and adolescents undergoing hemodialysis.Marques de Aquino T, Avesani CM, Brasileiro RS, de Abreu Carvalhaes JT.Marques de Aquino T, et al.J Ren Nutr. 2008 May;18(3):312-9. doi: 10.1053/j.jrn.2007.11.006.J Ren Nutr. 2008.PMID:18410889Clinical Trial.
- Pathogenesis of malnutrition in cystic fibrosis, and its treatment.Pencharz PB, Durie PR.Pencharz PB, et al.Clin Nutr. 2000 Dec;19(6):387-94. doi: 10.1054/clnu.1999.0079.Clin Nutr. 2000.PMID:11104588Review.
- Energy expenditure and genotype of children with cystic fibrosis.Tomezsko JL, Stallings VA, Kawchak DA, Goin JE, Diamond G, Scanlin TF.Tomezsko JL, et al.Pediatr Res. 1994 Apr;35(4 Pt 1):451-60. doi: 10.1203/00006450-199404000-00013.Pediatr Res. 1994.PMID:7519343Review.
Cited by
- Absence of leptin signaling allows fat accretion in cystic fibrosis mice.Bederman IR, Pora G, O'Reilly M, Poleman J, Spoonhower K, Puchowicz M, Perez A, Erokwu BO, Rodriguez-Palacios A, Flask CA, Drumm ML.Bederman IR, et al.Am J Physiol Gastrointest Liver Physiol. 2018 Nov 1;315(5):G685-G698. doi: 10.1152/ajpgi.00344.2017. Epub 2018 Aug 17.Am J Physiol Gastrointest Liver Physiol. 2018.PMID:30118352Free PMC article.
- Oral calorie supplements for cystic fibrosis.Smyth RL, Rayner O.Smyth RL, et al.Cochrane Database Syst Rev. 2017 May 4;5(5):CD000406. doi: 10.1002/14651858.CD000406.pub5.Cochrane Database Syst Rev. 2017.PMID:28470972Free PMC article.Review.
- Zinc status in cystic fibrosis patients; a systematic review and meta-analysis.Malekahmadi M, Soltani S, Pahlavani N, Sharifi Zahabi E, Kazemizadeh H, Hadavi S, Farsani GM.Malekahmadi M, et al.Heliyon. 2024 Jun 28;10(13):e33686. doi: 10.1016/j.heliyon.2024.e33686. eCollection 2024 Jul 15.Heliyon. 2024.PMID:39027558Free PMC article.Review.
- Trends in Growth and Maturation in Children with Cystic Fibrosis Throughout Nine Decades.Mason KA, Rogol AD.Mason KA, et al.Front Endocrinol (Lausanne). 2022 Jul 12;13:935354. doi: 10.3389/fendo.2022.935354. eCollection 2022.Front Endocrinol (Lausanne). 2022.PMID:35903281Free PMC article.Review.
MeSH terms
Substances
Related information
LinkOut - more resources
Full Text Sources
Medical